[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 3 (Junio) . - pp. 281-293

Título :	Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects
Tipo de documento:	texto impreso
Autores:	Bankole A. Johnson, Autor ; Stephanie S. O’Malley, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 281-293
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Alcoholismo, Terapia con medicamentos, Naltrexona, Pruebas neuropsicológicas, Taurina.
Resumen:	We examined kinetic and dynamic factors to determine the pharmacological and behavioral safety and tolerability of low versus high doses of an opiate antagonist, naltrexone (50 mg/day vs. 100 mg/day), and acamprosate (2 g/day vs. 3 g/day), a functional N-methyl-D-aspartate receptor antagonist, both independently and combined, among non-treatmentseeking, alcohol-dependent individuals.
Link:	./index.php?lvl=notice_display&id=31024

[artículo] Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects [texto impreso] / Bankole A. Johnson, Autor ; Stephanie S. O’Malley, Autor . - 2023 . - pp. 281-293.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 3 (Junio) . - pp. 281-293

Palabras clave:	Alcoholismo, Terapia con medicamentos, Naltrexona, Pruebas neuropsicológicas, Taurina.
Resumen:	We examined kinetic and dynamic factors to determine the pharmacological and behavioral safety and tolerability of low versus high doses of an opiate antagonist, naltrexone (50 mg/day vs. 100 mg/day), and acamprosate (2 g/day vs. 3 g/day), a functional N-methyl-D-aspartate receptor antagonist, both independently and combined, among non-treatmentseeking, alcohol-dependent individuals.
Link:	./index.php?lvl=notice_display&id=31024